Have NatWest Shares Hit a Wall?

NatWest’s Q1 impairment spike and weaker macro outlook expose margin pressure, making the pricey Evelyn deal harder to justify in a slowdown.

Mark Rogers Mark Rogers

NatWest (LON: NWG) shares have climbed roughly 62% over the past year, rewarding investors who backed the bank’s privatisation and recovery. Yet at 560.20p today, the stock has pulled back roughly 20% from its 52-week high of 705.40p, supported by a healthy 5.8% dividend yield. The Q1 earnings released on 1 May suggest that while the bank remains fundamentally solid, the easy gains of the rate-hiking cycle are firmly behind it.

The headline numbers looked solid enough. Operating profit before impairments climbed 15.7% year-on-year to £2.3 billion, and earnings per share jumped 15.5% to 17.9p. But one figure stood out, with impairment losses spiking to £283 million from £189 million in the same quarter last year, including £140 million coming from management’s revised economic assumptions.

When a bank suddenly reprovisions for credit losses, it’s because management sees the world differently. And management at NatWest clearly does. They’ve cut their GDP growth assumptions for 2026 to just 0.4%, down from prior forecasts, and now expect unemployment to peak at 5.7% instead of 5.4%. That may not sound dramatic, but in credit modelling terms it’s material.

The structural issue is net interest margin. Through 2024 and 2025, NatWest’s profitability rode the wave of wide lending spreads and deposit inflows that outpaced loan growth. Management warned investors this advantage was temporary. Now it’s starting to fade.

The margin itself expanded to 2.47% in Q1 from 2.27% a year ago, which sounds positive. But quarter-to-quarter compression remains a strategic hurdle as competition for savings intensifies and mortgage spreads normalise. While the bank’s massive structural hedge will act as a buffer – reinvesting older, lower yields to add an expected £1.5 billion to the top line in 2026 – it may only serve to offset retail deposit migration rather than fuel explosive growth.

This cautious reality was apparent when management nudged 2026 income guidance to the top end of its £17.2–£17.6 billion range. While the market initially cheered this earnings beat, driving a brief relief rally, the upgraded guidance exposes a clear medium-term revenue ceiling.

The dividend becomes harder to sustain in this context. Management has committed to a 50% payout ratio, meaning distributable profit needs to hold around £5.5 billion annually. With net interest income under structural pressure and credit costs normalising upward, hitting that figure requires the wealth acquisition to deliver exactly as planned.

That brings us to Evelyn Partners. Announced in February at £2.7 billion, the deal promised to shift NatWest’s revenue mix away from shrinking lending spreads and toward fee-generating wealth management. The logic was sound, wealth assets grow faster than retail deposits erode. The timing, though, looks questionable.

Advertisement

Wealth assets are cyclical, and this quarter showed it plainly. Assets under management and administration fell £1.8 billion in Q1, driven almost entirely by market movements and seasonal client outflows. Evelyn’s reported £69 billion asset base, valued at 9.7 times EBITDA, assumes continued momentum in client growth and market appreciation. Market gyrations could easily swing that assumption.

The capital cost is also severe, the Evelyn deal will reduce NatWest’s CET1 ratio by 130 basis points, from the current 14.3% to levels that force the bank to suspend buybacks until H1 2027. That timing is unfortunate, shares have rallied partly on generous capital return expectations, and now that well runs dry precisely when the share price needs momentum.

Management insists the deal will drive higher returns than buybacks, and the wealth division’s 21.1% return on equity in Q1 supports that. But integration risks are real. Evelyn has an office network across 21 locations and a distinct investment philosophy from Coutts, the centuries-old private bank NatWest already owns. Blending two wealthy client franchises whilst hitting £100 million in cost synergies and capturing cross-sell opportunities is a multi-year execution challenge, rather than a guaranteed win.

For investors, valuation now matters more than momentum. Trading at 8.25 times trailing earnings, NatWest no longer commands a hefty premium and sits tightly in line with peers like Barclays and Lloyds (both trading under 8.5x). While this fair valuation accounts for macroeconomic headwinds, it leaves little margin for error regarding the Evelyn Partners integration, especially in an economy where management has trimmed GDP assumptions.

Analyst sentiment reflects the ambiguity, with the consensus rating being a “Moderate Buy” with average price targets implying 13.5% upside from here. That’s not a ringing endorsement, it’s measured optimism at best. One analyst downgraded to “Market Perform” citing macroeconomic headwinds. Another cut price targets from 750p to 730p. The narrative has shifted from “strong recovery” to “execution watch.”

For income investors, the 5.8% yield covers a lot of sins. But it also rests on assumptions that look increasingly stretched. Profit margins are compressing, capital is being deployed to an untested acquisition, and credit is normalising upward. The yield can survive all three pressures, but not comfortably if they all hit simultaneously.

The bull case still makes sense. If NatWest executes the Evelyn integration, captures meaningful cross-sell to its 20 million customers, and stabilises its loan portfolio as credit losses peak, the shares could trade higher. Wealth management is genuinely a structural growth opportunity, and NatWest’s scale in distribution gives it an edge.

But that’s a multi-year story that requires patience and perfect execution. The share price has already reflected significant belief in that outcome. For now, the bank looks like a solid hold for income investors with a long time horizon, but not a compelling buy at current valuations for anyone else.

The margin squeeze is real, the Evelyn gamble is material, and the easy money from the privatisation narrative is spent. Unless management can prove the wealth acquisition thesis in the next two to three quarters, the shares risk grinding lower as the market reprices for slower growth and higher credit costs.